Lilly initiates phase I/II study of LY-3499446 in advanced solid tumors with KRAS G12C mutation Dec. 9, 2019
Synlogic begins phase I study of SYNB-1891 in advanced/metastatic solid tumors and lymphoma Dec. 9, 2019
Preliminary data presented for TN-383B in patients with relapsed or refractory multiple myeloma Dec. 9, 2019
AAV2 capsid fitness landscape allows systematic optimization of natural capsids for gene therapy Dec. 9, 2019
RSS